Holen Sie sich die Stockscreener-App
24.75
3.17%
0.76
Handel nachbörslich:
24.71
-0.04
-0.16%
Schlusskurs vom Vortag:
$23.99
Offen:
$23.99
24-Stunden-Volumen:
195.97K
Relative Volume:
4.32
Marktkapitalisierung:
$189.89M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-61.23M
KGV:
-1.8307
EPS:
-13.5194
Netto-Cashflow:
$22.49M
1W Leistung:
+27.38%
1M Leistung:
+32.00%
6M Leistung:
+102.70%
1J Leistung:
+66.00%
1-Tages-Spanne:
$23.67
$24.94
1-Wochen-Bereich:
$19.13
$24.94
52-Wochen-Spanne:
$7.75
$24.94
Assembly Biosciences Inc Stock (ASMB) Company Profile
Firmenname
Assembly Biosciences Inc
Sektor
Branche
Telefon
(833) 409-4583
Adresse
TWO TOWER PLACE, SOUTH SAN FRANCISCO
Vergleichen Sie ASMB mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ASMB
Assembly Biosciences Inc
|
24.75 | 184.06M | 0 | -61.23M | 22.49M | -13.52 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.92 | 99.42B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
561.55 | 58.99B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
432.52 | 56.35B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
646.60 | 39.02B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
307.51 | 34.25B | 3.81B | -644.79M | -669.77M | -6.24 |
Assembly Biosciences Inc Stock (ASMB) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-03-25 | Eingeleitet | Guggenheim | Buy |
| 2024-09-20 | Hochstufung | Jefferies | Hold → Buy |
| 2021-09-13 | Eingeleitet | H.C. Wainwright | Neutral |
| 2021-09-02 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2021-03-23 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2020-11-06 | Herabstufung | Jefferies | Buy → Hold |
| 2020-10-19 | Eingeleitet | Truist | Buy |
| 2019-10-16 | Eingeleitet | Mizuho | Buy |
| 2018-11-19 | Eingeleitet | Leerink Partners | Outperform |
| 2018-10-08 | Hochstufung | B. Riley FBR | Neutral → Buy |
| 2018-08-08 | Eingeleitet | Robert W. Baird | Outperform |
| 2018-04-13 | Herabstufung | Chardan Capital Markets | Buy → Neutral |
| 2018-01-05 | Eingeleitet | B. Riley FBR, Inc. | Neutral |
| 2017-11-08 | Eingeleitet | Jefferies | Buy |
| 2017-05-30 | Eingeleitet | Chardan Capital Markets | Buy |
Alle ansehen
Assembly Biosciences Inc Aktie (ASMB) Neueste Nachrichten
Assembly Biosciences Inc. stock outlook for YEARJuly 2025 News Drivers & Consistent Growth Stock Picks - Newser
How to use a screener to detect Assembly Biosciences Inc. breakoutsMarket Activity Report & Fast Exit Strategy with Risk Control - Newser
Intraday pattern recognizer results for Assembly Biosciences Inc.Inflation Watch & Real-Time Price Movement Reports - Newser
What the charts say about Assembly Biosciences Inc. todayPortfolio Performance Summary & Short-Term High Return Ideas - Newser
Analyzing drawdowns of Assembly Biosciences Inc. with statistical tools2025 Support & Resistance & Fast Gain Swing Alerts - Newser
Applying Wyckoff theory to Assembly Biosciences Inc. stockFed Meeting & Real-Time Chart Pattern Alerts - Newser
Published on: 2025-08-13 01:47:09 - Newser
Can you recover from losses in Assembly Biosciences Inc.Quarterly Portfolio Report & Entry and Exit Point Strategies - Newser
Is Assembly Biosciences Inc. stock poised for growthDaily Entry Opportunity Forecasting Tool - Newser
What makes Assembly Biosciences Inc. stock price move sharplyWeekly Market Direction and Sector Summary - Newser
Historical volatility pattern of Assembly Biosciences Inc. visualizedLow Volatility Stock Analysis With Confidence - Newser
Is a relief rally coming for Assembly Biosciences Inc. holdersRisk Balanced Picks for Safer Trading - Newser
Sector ETF performance correlation with Assembly Biosciences Inc.Watchlist Summary for Active Day Traders - Newser
Assembly Biosciences Raises $175 Million in Equity Financing - AInvest
Backtesting results for Assembly Biosciences Inc. trading strategiesRisk Adjusted Trade Signal Screening Tool - Newser
Long term hold vs stop loss in Assembly Biosciences Inc.Buy Alert Based on RSI and Volume - Newser
Automated trading signals detected on Assembly Biosciences Inc.Free Pattern Breakout Entry Stock Forecast - Newser
Assembly Biosciences Announces $175M Equity Financings, Raises $19.60/Sh. - AInvest
Assembly Biosciences Inc. Chart Enters High Volatility ZoneTop Gaining Picks With Entry Signals Identified - beatles.ru
There's No Escaping Assembly Biosciences, Inc.'s (NASDAQ:ASMB) Muted Revenues Despite A 28% Share Price Rise - simplywall.st
Published on: 2025-08-11 07:03:28 - Newser
Assembly Bio’s herpes drug shows 94% drop in viral shedding - Yahoo Finance
Using fundamentals and technicals on Assembly Biosciences Inc.Watchlist Generator for Smart Money Signals - Newser
Real time breakdown of Assembly Biosciences Inc. stock performanceAnnual Market Behavior and Sector Summary - Newser
Using AI based signals to follow Assembly Biosciences Inc.Swing Trade Watchlist with Entry Zones - Newser
Assembly Bio’s (ASMB) HBV Drug Shows Strong Efficacy in Phase 1b Trial - MSN
Assembly Biosciences Raises $175M in Equity Financing - AInvest
Assembly Biosciences' ABI-5366: A Catalyst for Genital Herpes Innovation and Shareholder Value - AInvest
Contrasting Acura Pharmaceuticals (OTCMKTS:ACUR) & Assembly Biosciences (NASDAQ:ASMB) - Defense World
Assembly Biosciences: Positive Data Of ABI-5366 Brings 2 Fall Program Catalysts (ASMB) - Seeking Alpha
Assembly Bio touts Phase 1b success in herpes as Gilead buys 2.3M shares - Endpoints News
Assembly Biosciences reports positive data from herpes study - Seeking Alpha
Assembly Biosciences announces pricing of $175M in equity financings - TipRanks
Assembly Biosciences reports interim results from phase 1b study of ABI-5366 - TipRanks
Assembly Biosciences Announces Positive Phase 1b Results - TipRanks
Assembly Bio prices $130 million offering to fund viral disease research - Investing.com India
Assembly Biosciences Reports Positive Interim Results for ABI-5366 in Phase 1b Study, Demonstrating Significant Reductions in HSV-2 Shedding and Genital Lesion Rates - Quiver Quantitative
Assembly Bio reports 94% reduction in HSV-2 shedding with new drug - Investing.com Australia
Assembly Bio reports 94% reduction in HSV-2 shedding with new drug By Investing.com - Investing.com South Africa
Assembly Biosciences raises $109.6M in underwritten, registered offering. - AInvest
Assembly Biosciences Raises $175M in Equity Financing, Gilead Sciences Invests $97M in Private Placement. - AInvest
Assembly Biosciences Reports Positive Interim Results from Phase 1b Clinical Study of Long-Acting Helicase-Primase Inhibitor Candidate ABI-5366 Showing Reductions in Viral Shedding Rate and Genital Lesion Rate in Recurrent Genital Herpes - Morningstar
Individual investors in Assembly Biosciences, Inc. (NASDAQ:ASMB) are its biggest bettors, and their bets paid off as stock gained 18% last week - simplywall.st
Finanzdaten der Assembly Biosciences Inc-Aktie (ASMB)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.67%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):